ATC Group: V09IX18 Flotufolastat (18F)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09IX18 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09I Tumour detection
4 V09IX Other diagnostic radiopharmaceuticals for tumour detection
5 V09IX18

Active ingredients in V09IX18

Active Ingredient Description
Flotufolastat ¹⁸F

Flotufolastat (18F) is a radioactive diagnostic agent for intravenous use. Flotufolastat (18F) binds to PSMA (IC50 = 4.4 nM) expressed on cells, including prostate cancer cells, and is internalized. Prostate cancer cells usually overexpress PSMA. Fluorine-18 is a β+ emitting radionuclide that can be detected using positron emission tomography.